These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 13705283)
1. Clinical evaluation local ocular anticholinesterase agents in myasthenia gravis. GILES CL; WESTERBERG MR Am J Ophthalmol; 1961 Sep; 52():331-40. PubMed ID: 13705283 [No Abstract] [Full Text] [Related]
2. Local administration of anticholinesterase agents in ocular myasthenia gravis. LEOPOLD IH; HEDGES TR; MONTANA J; KRISHNA N; BECKETT S Arch Ophthalmol; 1960 Mar; 63():544-7. PubMed ID: 14415845 [No Abstract] [Full Text] [Related]
3. The long-acting anticholinesterase drugs in the management of myasthenia gravis. ARANOW H; HOEFER PF; ROWLAND LP J Chronic Dis; 1957 Nov; 6(5):457-74. PubMed ID: 13475447 [No Abstract] [Full Text] [Related]
4. Treatment of anticholinesterase intoxication with oximes; use in normal subjects and in patients with myasthenia gravis. GROB D; JOHNS RJ J Am Med Assoc; 1958 Apr; 166(15):1855-8. PubMed ID: 13525162 [No Abstract] [Full Text] [Related]
5. Myasthenia gravis with ocular involvement in older patients. Weizer JS; Lee AG; Coats DK Can J Ophthalmol; 2001 Feb; 36(1):26-33. PubMed ID: 11227387 [TBL] [Abstract][Full Text] [Related]
6. [On the mechanism of action of some anticholinesterase preparations]. PEREL'MAN LB; PRIKHOZHAN VM; MATLINA ESh Biull Eksp Biol Med; 1962 May; 53():76-80. PubMed ID: 14485240 [No Abstract] [Full Text] [Related]
7. Treatment of myasthenia gravis: an audit. Simpson JA; Thomaides T Q J Med; 1987 Aug; 64(244):693-704. PubMed ID: 3328214 [TBL] [Abstract][Full Text] [Related]
8. [Blood cholinesterase during the treatment of myasthenia by anti-cholinesterase drugs (prostigmine and mestinon)]. VINCENT D; PLANQUES J; GERAUD J; DARDENNE P Therapie; 1960; 15():906-13. PubMed ID: 13781449 [No Abstract] [Full Text] [Related]
9. Ocular myasthenia gravis. March GA; Johnson LN J Natl Med Assoc; 1993 Sep; 85(9):681-4. PubMed ID: 8120928 [TBL] [Abstract][Full Text] [Related]
10. Ocular myasthenia gravis. Lee AG Curr Opin Ophthalmol; 1996 Dec; 7(6):39-41. PubMed ID: 10166551 [TBL] [Abstract][Full Text] [Related]
11. Essentials in the management of myasthenia gravis. Galdi AP Am Fam Physician; 1978 Jun; 17(6):95-102. PubMed ID: 655080 [TBL] [Abstract][Full Text] [Related]
12. Long-term prednisone followed by thymectomy in myasthenia gravis. Mann JD; Johns TR; Campa JF; Muller WH Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998 [TBL] [Abstract][Full Text] [Related]
13. Use of oximes in the treatment of intoxication by anticholinesterase compounds in patients with myasthenia gravis. GROB D; JOHNS RJ Am J Med; 1958 Apr; 24(4):512-8. PubMed ID: 13520752 [No Abstract] [Full Text] [Related]
14. Treatment of ocular symptoms in myasthenia gravis. Bhanushali MJ; Wuu J; Benatar M Neurology; 2008 Oct; 71(17):1335-41. PubMed ID: 18936425 [TBL] [Abstract][Full Text] [Related]
20. The long term experience of thymectomy for myasthenia gravis. Scadding GK; Havard CW; Lange MJ; Domb I J Neurol Neurosurg Psychiatry; 1985 May; 48(5):401-6. PubMed ID: 3998750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]